News | SummitMD

Coronary CTA on Asymptomatic Patients Provides Little to No Clinical Benefit

Asan Medical Center research team finds increasing rate of coronary CTAs on domestic asymptomatic patients but little subsequent diagnostic, survival benefit

News | SummitMD

Aspirin Alone Better for Post-TAVI Patients not on Anticoagulation: POPular TAVI

Study comparing aspirin+clopidogrel vs. aspirin shows aspirin alone reduced risk of all bleeding with no increased thrombotic risk for post-TAVI patients not on oral anticoagulation

News | SummitMD

2nd SGLT-2 Inhibitor Scores in HF as Empagliflozin Reduces Hospitalization, CV Death in HFrEF

EMPEROR-Reduced: diabetes drug empagliflozin shows significant CV, renal benefits in HFrEF regardless of diabetes status

News | SummitMD

Infectious Disease Expert Calls for Distinct Treatment Strategies for Heart Patients with COVID-19

Professor Kim Sung-Han Highlights Importance of Non-Pharmaceutical Interventions for COVID-19 Prevention, Vaccine Development for Herd Immunity.

News | SummitMD

Argument for RAAS Inhibitors¡¯ Safety During COVID-19 Pandemic Solidifies Despite Controversy

Various Research Indicates ACE Inhibitors, Arbs Do Not Increase Risk of Infection or More Severe Illness